皓宸医疗
(002622)
| 流通市值：24.70亿 | | | 总市值：24.70亿 |
| 流通股本：8.40亿 | | | 总股本：8.40亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 126,548,983.48 | 147,693,180.87 | 154,125,521.53 | 130,816,113.68 |
| 应收票据及应收账款 | 36,572,250.86 | 48,210,598.32 | 38,945,614.05 | 37,136,953.5 |
| 其中：应收票据 | 4,477,285.29 | 9,041,164.44 | 11,544,225.63 | 13,646,843.05 |
| 应收账款 | 32,094,965.57 | 39,169,433.88 | 27,401,388.42 | 23,490,110.45 |
| 预付款项 | 11,980,245.07 | 6,954,032.08 | 15,016,494.9 | 17,584,113.5 |
| 其他应收款合计 | 44,862,651.37 | 40,326,226.96 | 42,636,308.72 | 44,047,910.82 |
| 应收股利 | 22,700,000 | 22,700,000 | 22,700,000 | 22,700,000 |
| 存货 | 49,266,292.91 | 50,753,348.55 | 59,474,920.03 | 64,009,052.31 |
| 其他流动资产 | 2,493,520.35 | 2,485,124.07 | 2,122,097.53 | 2,105,858.68 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 271,723,944.04 | 296,422,510.85 | 313,035,141.47 | 296,414,187.2 |
| 非流动资产: | | | | |
| 长期股权投资 | 475,849,990.1 | 476,317,660.06 | 499,532,663.69 | 495,227,662.79 |
| 其他权益工具投资 | 11,000,000 | 11,000,000 | 11,800,000 | 11,800,000 |
| 投资性房地产 | 30,898,211.82 | 31,241,592.24 | 31,584,972.66 | 31,928,353.08 |
| 固定资产 | 157,186,024.33 | 160,462,952.57 | 163,490,175.39 | 166,262,287 |
| 使用权资产 | 158,393,072.08 | 166,620,254.74 | 185,247,849.44 | 189,766,784.02 |
| 无形资产 | 47,358,318.66 | 48,294,719.84 | 48,263,956.35 | 47,554,001.35 |
| 商誉 | 199,672,759.15 | 199,672,759.15 | 199,672,759.15 | 199,672,759.15 |
| 长期待摊费用 | 58,002,531.89 | 60,127,111.92 | 63,373,020.37 | 64,033,009.76 |
| 递延所得税资产 | 47,096,496.44 | 47,324,082.17 | 49,746,626.45 | 49,599,158.78 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,185,457,404.47 | 1,201,061,132.69 | 1,252,712,023.5 | 1,255,844,015.93 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,457,181,348.51 | 1,497,483,643.54 | 1,565,747,164.97 | 1,552,258,203.13 |
| 流动负债: | | | | |
| 短期借款 | 191,458,466.67 | 191,588,304.03 | 113,528,594.44 | 113,729,175 |
| 应付票据及应付账款 | 62,748,164.16 | 60,297,291.97 | 71,369,890.97 | 69,626,417.83 |
| 应付账款 | 62,748,164.16 | 60,297,291.97 | 71,369,890.97 | 69,626,417.83 |
| 合同负债 | 118,867,294.93 | 124,737,128.05 | 139,267,140.68 | 152,960,561.63 |
| 应付职工薪酬 | 28,647,952.52 | 31,784,754.19 | 28,737,282.08 | 25,693,020.54 |
| 应交税费 | 2,250,854.98 | 6,953,260.67 | 3,886,099.19 | 3,496,002.28 |
| 其他应付款合计 | 336,674,069.84 | 332,863,567.48 | 313,863,412.58 | 309,429,108.07 |
| 其中:应付利息 | 74,028,652.63 | 69,657,936.53 | 65,171,762.66 | 60,629,767.76 |
| 一年内到期的非流动负债 | 132,941,098.99 | 134,470,301.8 | 221,453,389.48 | 219,647,703 |
| 其他流动负债 | 1,353,969.77 | 4,382,216.99 | 1,241,922.51 | 1,915,397.75 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 874,941,871.86 | 887,076,825.18 | 893,347,731.93 | 896,497,386.1 |
| 非流动负债: | | | | |
| 租赁负债 | 144,997,475.9 | 151,095,010.4 | 163,338,116.8 | 168,834,887.62 |
| 递延收益 | 8,549,937.59 | 8,661,684.77 | 8,773,431.95 | 8,885,179.13 |
| 递延所得税负债 | 7,412,958.13 | 7,602,828.98 | 7,863,151.09 | 8,081,113.77 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 160,960,371.62 | 167,359,524.15 | 179,974,699.84 | 185,801,180.52 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,035,902,243.48 | 1,054,436,349.33 | 1,073,322,431.77 | 1,082,298,566.62 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 840,000,000 | 840,000,000 | 840,000,000 | 840,000,000 |
| 资本公积 | 21,685,838.28 | 21,685,838.28 | 21,685,838.28 | 21,685,838.28 |
| 其他综合收益 | -52,420,201.46 | -48,655,667.52 | -50,057,613.5 | -49,587,133.07 |
| 盈余公积 | 40,813,718.28 | 40,813,718.28 | 40,813,718.28 | 40,813,718.28 |
| 未分配利润 | -468,023,295.43 | -455,808,714.88 | -404,621,157.69 | -417,564,331.89 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 382,056,059.67 | 398,035,174.16 | 447,820,785.37 | 435,348,091.6 |
| 少数股东权益 | 39,223,045.36 | 45,012,120.05 | 44,603,947.83 | 34,611,544.91 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 421,279,105.03 | 443,047,294.21 | 492,424,733.2 | 469,959,636.51 |
| 负债和股东权益合计 | 1,457,181,348.51 | 1,497,483,643.54 | 1,565,747,164.97 | 1,552,258,203.13 |
| 公告日期 | 2025-04-26 | 2025-04-26 | 2024-10-31 | 2024-08-30 |
| 审计意见(境内) | | 带强调事项段的无保留意见 | | |